# Ascending Multi-dose Study of REGN727(SAR236553) With and Without Concomitant Atorvastatin

> **NCT01161082** · PHASE1 · COMPLETED · sponsor: **Regeneron Pharmaceuticals** · enrollment: 72 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** REGN727(SAR236553)

## Key facts

- **NCT ID:** NCT01161082
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2015-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01161082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01161082, "Ascending Multi-dose Study of REGN727(SAR236553) With and Without Concomitant Atorvastatin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01161082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*